Difficulty: Medium
Average Score: 84%
Practice
You are explaining the risk of leukemia in children with Down syndrome to medical students; your discussion will include all the following statements EXCEPT
Correct answer
C
Rationale
Rationale:
The correct answer is C) children with Down syndrome have a slightly inferior outcome ratio of ALL/AML in general. This statement is incorrect because research shows that children with Down syndrome have a better outcome when they develop leukemia compared to children without Down syndrome. This is due to the unique genetic and immunological characteristics of individuals with Down syndrome that make them more responsive to certain treatments.
Option A is incorrect because acute leukemia does indeed occur more frequently in children with Down syndrome than in the general population due to the genetic predisposition associated with Down syndrome.
Option B is incorrect as AML (Acute Myeloid Leukemia) is more common in children with Down syndrome compared to ALL (Acute Lymphoblastic Leukemia) as Down syndrome predisposes individuals to myeloid leukemia.
Option D is incorrect as children with Down syndrome who develop AML actually demonstrate remarkable sensitivity to antimetabolites, making them more responsive to this type of chemotherapy.
In an educational context, understanding the specific risks and outcomes of leukemia in children with Down syndrome is crucial for medical students to provide appropriate care and treatment to this unique patient population. By understanding these nuances, future healthcare providers can tailor their approach to effectively manage leukemia in children with Down syndrome.
The correct answer is C) children with Down syndrome have a slightly inferior outcome ratio of ALL/AML in general. This statement is incorrect because research shows that children with Down syndrome have a better outcome when they develop leukemia compared to children without Down syndrome. This is due to the unique genetic and immunological characteristics of individuals with Down syndrome that make them more responsive to certain treatments.
Option A is incorrect because acute leukemia does indeed occur more frequently in children with Down syndrome than in the general population due to the genetic predisposition associated with Down syndrome.
Option B is incorrect as AML (Acute Myeloid Leukemia) is more common in children with Down syndrome compared to ALL (Acute Lymphoblastic Leukemia) as Down syndrome predisposes individuals to myeloid leukemia.
Option D is incorrect as children with Down syndrome who develop AML actually demonstrate remarkable sensitivity to antimetabolites, making them more responsive to this type of chemotherapy.
In an educational context, understanding the specific risks and outcomes of leukemia in children with Down syndrome is crucial for medical students to provide appropriate care and treatment to this unique patient population. By understanding these nuances, future healthcare providers can tailor their approach to effectively manage leukemia in children with Down syndrome.